AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.4920
+0.0186 (3.93%)
At close: May 12, 2025, 4:00 PM
0.4920
0.00 (0.00%)
After-hours: May 12, 2025, 8:00 PM EDT
AEON Biopharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
5.18M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
AEON News
- 17 days ago - AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance - GlobeNewsWire
- 21 days ago - AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
- 21 days ago - AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer - GlobeNewsWire
- 6 weeks ago - AEON Biopharma Announces CEO Transition - GlobeNewsWire
- 7 weeks ago - AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference - GlobeNewsWire
- 2 months ago - AEON Biopharma, Inc. Announces Reverse Stock Split - GlobeNewsWire
- 3 months ago - AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewsWire